Graves' disease (GD) is a common organ-specific autoimmune disorder inherited as a complex trait. Although there has not been consensus regarding the genuine susceptibility alleles, many population-based genetic studies showed association of the cytotoxic T-lymphocyte antigen-4 (CTLA4) gene with GD. In contrast, evidence utilizing family-based studies came only from the Caucasian population. Here we performed a family-based association study in the Han population in Taiwan. We enrolled 374 affected individuals and 347 unaffected family members in 151 GD pedigrees. Four single-nucleotide polymorphisms (SNP) and a short tandem repeat polymorphism (STRP) at CTLA4 were genotyped. Association of GD with a novel risk SNP at the 5 0 upstream region, CTLA4_À1722_T/C (rs733618), was demonstrated (P ¼ 0.0096). We also replicated the association signal of a coding SNP, CTLA4_ þ 49_G/A (rs231775, P ¼ 0.0219). A common haplotype composed of CTLA4_À1722_T/C and CTLA4_(AT)n (an STRP marker: UniSTS:48500) showed protective effect (P ¼ 0.0004). Our results of family-based association study, taken together with those from the Caucasian population, provide evidence that CTLA4 confers susceptibility to GD across different ethnic backgrounds.
Introduction
Graves' disease (GD) is a common organ-specific autoimmune disorder manifested with hyperthyroidism, diffuse goiter, thyroid-specific antibodies, with or without ophthalmopathy and dermopathy. 1 The prevalence of GD in the general population is between 1.0 and 2.0%. [2] [3] [4] The cause of GD is multifactorial, with considerable genetic influence. 1, 5 The evidence of the genetic contribution to its pathogenesis comes from the observation of family clustering, 6 an increased risk ratio between 8 and 15 of patients' female siblings 6, 7 and a higher concordance rate in monozygotic twins (0.35) than in dizygotic twins (0.03). 8 A statistical model based on the data from 8966 pairs of Danish twins demonstrated that nearly 80% of the predisposition to GD could be attributed to genetic factors. 8 However, being short of a common Mendelian inheritance pattern in pedigree analysis suggests a polygenic nature in its inheritance. 9, 10 Cytotoxic T-lymphocyte antigen-4 (CTLA4) is an immunoregulatory molecule expressed on the surface of T lymphocytes and serves as a key negative regulator.
11 CTLA4 gene located on chromosome 2q33 is among the most plausible candidate genes for GD. 10, 12, 13 Many population-based association studies in different ethnic backgrounds have shown positive results, 10 although negative results have also been reported. 14, 15 The most frequently reported risk single-nucleotide polymorphisms (SNPs) were CTLA4_ þ 49_G/A (rs231775, at exon 1), CTLA4_À319_C/T (rs5742909, at the promoter region) and CTLA4_(AT)n (UniSTS:48500, a short tandem repeat polymorphism (STRP) marker at the 3 0 untranslated region of CTLA4). 10,12,13 Ueda et al.
16
reported a comprehensive SNP fine mapping and proposed that the SNPs at the 3 0 uncoding region, such as CTLA4_CT60_G/A (rs3087243, at the 3 0 downstream region), are the primary disease determinants. Nevertheless, more studies are probably needed to reveal the genuine causative genetic variants.
In contrast to the population-based studies, there were only a few family-based genetic studies of GD regarding CTLA4. Up to now, only three family-based studies in the United Kingdom observed linkage or association signal of GD at the CTLA4 gene. [16] [17] [18] Population-based genetic association studies in outbred populations may be prone to false-positive finding caused by population stratification. 19, 20 This can be avoided by a family-based design. 21 Therefore, we enrolled 721 individuals in 151 pedigrees with one or more affected persons in Han population in Taiwan. Family-based association study was performed with five markers of CTLA4 previously reported to be associated with GD or other autoimmune diseases to detect the association between CTLA4 and GD and to identify potential risk alleles in our population.
Results
Genotypes of four SNPs (CTLA4_À1722_T/C, CTLA4_À1147_C/T, CTLA4_ þ 49_G/A and CTLA4_ CT60_G/A) and a dichotomized STRP marker (CTLA4_ (AT)n_O/S) were analyzed with TRANSMIT v2.54 for family-based association study. 22 The basic information of these markers and allele frequency in our samples are summarized in Table 1 . The allele frequencies of all these SNP markers were compatible with Hardy-Weinberg equilibrium. The relative positions of these markers at CTLA4 gene are shown in Figure 1 . For single-marker analysis, our strongest association signal was observed at a 5 0 upstream SNP, CTLA4_À1722_T/C, with its minor allele (C allele) over-transmitted to affected individuals (w 2 ¼ 6.714, d.f. ¼ 1, nominal P ¼ 0.0096, Table 1 ). This is the first study to implicate the association of this SNP with GD. We also replicated the association signal at another SNP, CTLA4_ þ 49_G/A (w 2 ¼ 5.252, d.f. ¼ 1, nominal P ¼ 0.0219, G allele over-transmitted), which has been reported previously. 10, 12, 16 Linkage disequilibrium (LD) between these five markers was analyzed with Haploview v3.32. 23 All the four SNP markers, but not the STRP marker, are in strong LD (Figure 1 ), which is compatible with previous reports. 16, 24 We applied TRANSMIT to perform familybased association analysis using haplotypes from all the possible two-marker combinations. The result is presented in Table 2 . Eight of the 10 combinations had at least one haplotype with a nominal P-value less than 0.05. The most significant cluster was related to CTLA4_À1722_T/C; all of its four two-marker combinations had at least one haplotype with nominal P-value less than 0.05, and three of its four two-marker combinations had one haplotype with nominal P-value less than 0.01. Our strongest two-marker association signal was from a common haplotype (34.5% of the population) composed of the CTLA4_À1722_T allele and the CTLA4_(AT)n_O allele (w 2 ¼ 12.576, d.f. ¼ 1, P ¼ 0.0004). This haplotype was under-transmitted to the affected individuals, which indicated a protective role.
Discussion
We report an association of CTLA4 with GD in a familybased study in the Han population in Taiwan. Previously, the only three family-based studies on the association between CTLA4 and GD were all performed in Caucasians. [16] [17] [18] Family-based study design has the advantage of overcoming possible spurious positive caused by population stratification. [19] [20] [21] However, in family-based study, compared to the population-based study, it is difficult to recruit enough sample size for adequate power and also to estimate the odds ratio for the risk allele. These results provide robust evidence of the association between CTLA4 and GD in the Han population in Taiwan. Our strongest association signals were observed at a novel risk SNP, CTLA4_À1722_T/C, and The sign in this column is the sign of w 2 statistics of the minor allele. The plus sign means over-transmission of the minor allele, and the minus sign under-transmission. CTLA4 polymorphisms and Graves' disease P-L Chen et al haplotypes containing it. This SNP was never shown to be associated with GD before, but was previously reported to be associated with systemic lupus erythematosus (SLE) in two studies. 25, 26 Our most significant result was found in a twomarker combination containing CTLA4_À1722_T/C and CTLA4_(AT)n markers (P ¼ 0.0004). The marker CTLA4_(AT)n has been shown to be associated with GD in a couple of studies. 12, 27, 28 In our current report, we dichotomized this STRP marker into 'allele S' (standing for the 'Specific' allele, which is the same as the 'allele 106' of Yanagawa et al.
27 study) and 'allele O' (standing for the 'Other' alleles). The direction of allele effect was found to be consistent between previous reports ('allele 106' as the risk allele) and our study ('allele O' to be in the protective haplotype).
We also noticed that the CTLA4_(AT)n marker was not in strong LD with other markers, judging from the measurement of D 0 (Figure 1a ) and R 2 ( Figure 1b) . One explanation for the highly significant association signal from the two-marker combination is that a 'single' causal genetic variant was not genotyped in our study and its information could be captured by the haplotypes defined by these two markers. The alternative explanation is that there are two (or even more) different causal variants at the CTLA4 gene, and CTLA4_À1722_T/C and CTLA4_(AT)n represented independent signals. Ueda et al. 16 , with the statistical model attempting to detect a CTLA4 polymorphisms and Graves' disease P-L Chen et al single causal variant at CTLA4, proposed that one SNP at the 3 0 uncoding region is the primary disease determinant. However, their data were unable to exclude the possibility of multiple causative variants.
Our study should be considered as a hypothesistesting approach because all of the five markers have previously been reported to be associated with GD or other autoimmune diseases. This kind of approach affects our analysis in two major ways. First, this set of markers are not tagging markers, which means that further exhaustive haplotype analyses (three-, four-and five-marker haplotype analysis) may not give us interpretable results. The current single-marker and twomarker analyses can be viewed as tests for individual and joint (or interaction) effect of these candidate markers. Second, it will be very difficult to adapt an appropriate method to correct for multiple testing. Having been previously reported of association, these markers actually have a higher a priori to be the true signal; being in LD with each other and inside the same LD block (Figure 1 ), the penalty for multiple testing should be reduced. 29 Therefore in this manuscript, we only report the nominal P-values and leave the issue of correction for multiple testing untouched. Nonetheless, it is obvious that our best association signals remain significant even under the most stringent Bonferroni correction.
By comparing our genotypes of the unrelated founders and those in public database, we noticed allele frequency difference across populations of a couple of SNPs at the CTLA4 gene region. For example, the frequency of the CTLA4_À1722_C allele in our samples was 42.6%, which is comparable with that of the Chinese Han in Beijing (CHB) samples of the HapMap project (33.3%), 30 but very different from that of the Utah residents with ancestry from northern and western Europe (CEU) samples (5.8%). Figure 2 demonstrates the allele frequency of CTLA4_À1722_T/C, CTLA4_ þ 49_G/A and CTLA4_CT60_G/A. The allele frequency difference of these three SNPs between Caucasian samples and our Han samples in Taiwan was highly significant. It might partially explain why the association study of CTLA4 gave inconsistent results among different ethnic populations. We suggest that any attempt of applying the risk (or protective) alleles/haplotypes information at CTLA4 across populations should be done with great caution. Interestingly, four tagSNPs were suggested to cover the 16.18 kb region of CTLA-4 gene in CHB and Japanese in HapMap, similar to the number used in our study.
With the same collection of familial samples, we did not detect evidence of linkage at the CTLA4 region, 31 which could be explained by the effect size of CTLA4 and by the sample size of our collection. However, we were able to demonstrate significant linkage (NPL score ¼ 4.1, P ¼ 0.00002) at the human leukocyte antigen region. 31 With an intention to reduce heterogeneity of our samples, we purposely enrolled individuals with only Han ethnic background, and collected GD-only pedigrees by excluding families with a history of hypothyroidism or Hashimoto's thyroiditis. With this strategy of sample collection, we successfully detected linkage signal of human leukocyte antigen and association signal of CTLA4. It is likely that this collection may contribute our genetic study at other regions in the future.
In conclusion, our family-based association study demonstrates that the CTLA4 gene is associated with GD in the Han population in Taiwan. We identified a novel risk SNP in the 5 0 flanking region (CTLA4_À 1722_T/C). A two-marker combination consisted of the CTLA4_À1722_T allele and the CTLA4_(AT)n_O allele showed protective effect. We also replicated the association of CTLA4_ þ 49_G allele with GD. Our results of family-based association study, taken together with those from the Caucasian population, provide robust evidence that CTLA4 confers susceptibility to GD across different ethnic backgrounds.
Subjects and methods
Clinical assessment and family ascertainment Pedigrees were ascertained through a GD proband as previously described. 31 Briefly, the diagnosis of GD was made based on the manifestations of biochemical hyperthyroidism with either ophthalmopathy or a diffuse goiter and a significant titer of auto-antibodies, including antimicrosomal, antithyroglobulin or anti-TSH receptor antibody as in previous reports. 31, 32 To increase phenotypic homogeneity, pedigrees containing any member with possible Hashimoto's thyroiditis (HT [MIM603372], based either on medical records of HT or on self-stated history of symptoms/signs of hypothyroidism without previous treatment of thyroidectomy or radioactive iodine) were excluded. To reduce heterogeneous ethnic background, only subjects with four grandparents of Han origin were included. Those patients with ancestors of possible Taiwanese aboriginal (of Pacific-Polynesian origin) or other minority Chinese ethnicity were not enrolled. This project was approved by the Ethic Committee of Human Research of National Taiwan University Hospital. Written informed consent was obtained from each individual.
This report included 721 individuals in 151 pedigrees. Among the pedigrees, 6 (4.0%) had one affected individual, 100 (66.3%) had two, 28 (18.5%) had three, 8 (5.3%) had four, 7 (4.6%) had five, 1 (0.7%) had seven and 1 (0.7%) had 10 affected individuals in one family. There were 374 affected patients, including 300 females (80.2%) and 74 males (19.8%). Of the 347 unaffected family members, 156 were females and 191 males.
Genotyping
Genomic DNA was extracted from peripheral leukocytes using the PureGene kit following the protocol from the manufacturer (Gentra Systems Inc., Minneapolis, MN, USA). Four SNPs at the CTLA4 gene region were genotyped, including CTLA4_À1722_T/C (rs733618), CTLA4_À1147_C/T (rs16840252), CTLA4_ þ 49_G/A (rs231775) and CTLA4_CT60_G/A (rs3087243). Genotyping was performed using LightCycler (Roche Diagnostics, Basel, Switzerland) or a matrix-assisted laser desorption ionization-time of flight-based method with MassARRAY (Sequenom Inc., San Diego, CA, USA) as previously described. 33 The sequence information for primer and probe design was based on the public genome database (http://www.ncbi.nlm.nih.gov). To genotype the STRP marker CTLA4_(AT)n, fluorescencelabeled primers were purchased from Applied Biosystems. PCR was performed in a 10-ml reaction volume containing 25 ng of genomic DNA and 1 U of AccuPrime Taq polymerase (Invitrogen Corp., Carlsbad, CA, USA) according to the standard protocol. After PCR, 3 ml of the product was mixed with 0.5 ml of internal size standard and 10 ml of deionized formamide, denatured and separated using an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Allele calling was performed by using Genotyper Software v3.7 (Applied Biosystems, Foster City, CA, USA). Each genotype was independently reviewed by two members of the research team. The sequences of primers and probes are available upon request.
Statistical analyses
Mendelian inheritance consistency of all markers in individual pedigree was checked with PedCheck version 1.1 to confirm the family structure and genotyping correctness. 34 Those genotypes with initial Mendelian inconsistency were rechecked, and corrected if obvious mistake was identified, or set as missing. All the pedigrees included in this report are compatible with Mendelian inheritance. For all the four SNPs, HardyWeinberg equilibrium was also checked using the genotype frequency of unrelated founders. None of the SNPs reported in this study was against HardyWeinberg equilibrium.
We applied TRANSMIT v2.54 software to conduct family-based association study. 22 TRANSMIT adapts a score test based on a partial score function that omits the terms most influenced by hidden population stratification. Option '-ro' was applied to use the robust estimate of the variance of the score vector. In a region without evidence of linkage, TRANSMIT can handle uncertainty for multilocus haplotypes, allow parental genotypes to be unknown and deal with more than one affected offspring per family. Therefore it is appropriate for our study. Haploview v3.32 was used to analyze LD between markers. The 'solid spine' option was applied to define LD blocks. 23 In our current report, we dichotomized the STRP marker into 'allele S' (standing for the 'Specific' allele, which is the same as the 'allele 106' of Yanagawa et al.
27 study) and 'allele O' (standing for the 'Other' alleles).
The allele frequencies in Figure 2 other than our genotyping results were from the HapMap project, 30 except for that of þ 49_G/A of CEU, which was from dbSNP (http://www.ncbi.nlm.nih.gov/SNP/index.html) because of the lack of information in HapMap. The allele frequencies for our own results were estimated from the genotypes of unrelated founders of the families.
